Company profile:

Jiangxi Nuobang Biological Pharmaceutical Co., Ltd.

Country: China
Legal Representative: Wen Tao
Business status: Active
Industry: Manufacturing of Veterinary Drugs
Company type: other limited liability companies
Founding date: 2020-07-08
Approval date: 2023-06-19
Chinese company name: 江西*邦生物科技有限公司
Telephone: 0794-52800** ,52800**
Email: **nb2022@163.com , **tebang@163.com , **0447886@qq.com ,

Jiangxi Nuobang Biological Pharmaceutical Co., Ltd.

Employees 0-100 Detail ( 72.48% of companies have fewer than 5 employees. )
Registered capital 50,000,000 RMB Detail ( 6.3% of companies have registered capital less than 500,000. )
Paid up capital 50-100 Million RMB Detail ( 42.7% of companies have paid up capital less than 500,000. )
The preceding data analysis is derived from a sample of 2 million Chinese companies with import and export licenses, as of October 9, 2023.

Company's Shareholders

Fuzhou Beite Enterprise Management Center (Limited Partnership)
Wen Tao
Shenzhen Benuo Enterprise Management Consulting Partnership (Limited Partnership)

They invested companies

Company's business scope

licensed items:Veterinary drug productionVeterinary drug businessFeed additive productionProduction of hygiene products and single-use medical productsDrug import and exportDisinfectant production(Free of Hazardous Chemicals)(Items subject to approval by law,Business activities can only be carried out within the validity period of the license after being approved by the relevant department,The specific business items and license period are subject to the approval documents or licenses of relevant departments)General project:Sales of hygiene products and single-use medical productsFeed Additive SalesTechnical Servicestechnology developmenttechnical consultingTechnology Exchangetechnology transferTechnology PromotionImport and export agency,Domestic trade agent,Domestic Freight Forwarding,Disinfectant sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Report on this company:

Supplier Verification
$29
  • Company General Information
  • Company Registration Details
  • Shareholder Information
  • Main Personnels
  • Import & Export Credit
  • Legal Records Table
  • Government Records Table
Full Background Check
$99
  • Company General Information
  • Company Registration Details
  • Shareholder Information
  • Main Personnels
  • Import & Export Credit
  • Legal Records Table
  • Government Records Table
  • Company Change Record
  • Company Legal Inspection
  • Ongoing Judicial Case
  • Case Filings History
  • Administrative Penalties
  • Related Companies Risks
Pre-litigation Investigation
$199
  • Company General Information
  • Company Registration Details
  • Shareholder Information
  • Main Personnels
  • Import & Export Credit
  • Legal Records Table
  • Government Records Table
  • Company Change Record
  • Company Legal Inspection
  • Ongoing Judicial Case
  • Case Filings History
  • Administrative Penalties
  • Related Companies Risks
  • Branches & Subsidiaries
  • Advanced Registration Information
  • Legal Representative Information
  • Suspected Actual Controller
  • Company Investment
  • Company Annual Report
  • Company Intellectual Property

location of Jiangxi Nuobang Biological Pharmaceutical Co., Ltd.

Address Building A1, Biotechnology Industrial Park, West High-tech Zone, Jinxi County, Fuzhou City, Jiangxi Province
Province Jiangxi China Jiangxi
City Fuzhou

Ranking of Fuzhou Among Chinese Cities

Area of Industrial, Manufacturing of the city(Fuzhou )

Area: 23.82 km²
Chinese city rankings: 109

Population of the city(Fuzhou )

Population: 1,718,000
Chinese city rankings: 95

Companies in the city(Fuzhou)

Companies: 1,441
Chinese city rankings: 120

Area of Logistics and Warehouse of the city(Fuzhou )

Area: 2.01 km²
Chinese city rankings: 157

Frequently Asked Questions

1.Company information

Email:**0447886@qq.com

Phone number:0794-52800**

The company was started in 2020-07-08